- Home
- PRTA vs TALK Comparison
PRTA vs TALK Comparison
Compare PRTA & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- TALK
- Stock Information
- Founded
- PRTA 2012
- TALK 2012
- Country
- PRTA Ireland
- TALK United States
- Employees
- PRTA N/A
- TALK N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- TALK Medical/Nursing Services
- Sector
- PRTA Health Care
- TALK Health Care
- Exchange
- PRTA Nasdaq
- TALK Nasdaq
- Market Cap
- PRTA 643.0M
- TALK 534.6M
- IPO Year
- PRTA N/A
- TALK N/A
- Fundamental
- Price
- PRTA $13.77
- TALK $3.02
- Analyst Decision
- PRTA Buy
- TALK Buy
- Analyst Count
- PRTA 7
- TALK 5
- Target Price
- PRTA $46.50
- TALK $4.38
- AVG Volume (30 Days)
- PRTA 711.1K
- TALK 1.2M
- Earning Date
- PRTA 02-13-2025
- TALK 02-20-2025
- Dividend Yield
- PRTA N/A
- TALK N/A
- EPS Growth
- PRTA N/A
- TALK N/A
- EPS
- PRTA N/A
- TALK N/A
- Revenue
- PRTA $133,350,000.00
- TALK $181,291,000.00
- Revenue This Year
- PRTA $56.89
- TALK $28.22
- Revenue Next Year
- PRTA N/A
- TALK $23.48
- P/E Ratio
- PRTA N/A
- TALK N/A
- Revenue Growth
- PRTA N/A
- TALK 31.50
- 52 Week Low
- PRTA $11.70
- TALK $1.60
- 52 Week High
- PRTA $34.75
- TALK $3.92
- Technical
- Relative Strength Index (RSI)
- PRTA 48.19
- TALK 46.07
- Support Level
- PRTA $12.39
- TALK $2.77
- Resistance Level
- PRTA $13.64
- TALK $3.11
- Average True Range (ATR)
- PRTA 1.03
- TALK 0.15
- MACD
- PRTA -0.02
- TALK -0.01
- Stochastic Oscillator
- PRTA 40.47
- TALK 44.64
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.